FABP7 and neoplasm: There are also a number of samples that appear to have relatively high tumor content (>1%) for SCGB2A2 and FABP7, but for which the genes are not detected in cfRNA, suggesting that other factors beyond tumor tissue expression may influence the detectability of a given biomarker in circulation.